Agilent's technology is helping industries advance discovery and development in cannabinoid research and assisting regulators in upholding hemp product safety and quality standards
Thomas Neubert, PhD, talks to contributing editor Tanuja Koppal, PhD, about analyzing small molecules and proteins from diverse samples using mass spectrometry (MS).
Applicable to a variety of pharmaceutical antibodies, this proprietary technique enables selective proteolysis of the Fab region of monoclonal antibodies to dramatically improve the productivity and robustness of LCMS mAB bioanalysis